Concepedia

Bernd Gerhartz

BG

28

Publications

1.8K

Citations

22

H-Index

1997

Active since

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

Novartis (United States)

Probiodrug (Germany)

Ludwig-Maximilians-Universität München

Bernd Gerhartz is an author at Novartis (Switzerland) specializing in medicine, biochemistry, and natural sciences.

Top concepts

Publications per year

1997–2020

28

Publications

28

Inhibition of Mammalian Legumain by Some Cystatins Is Due to a Novel Second Reactive Site

Marcia Alvarez-Fernandez, A. John Barrett, Bernd Gerhartz et al. · Journal of Biological Chemistry · 1999 · 281 citations · Full text

Structural Basis of Ubiquitin Recognition by the Deubiquitinating Protease USP2

Martin Renatus, S.G. Parrado, A. D’Arcy et al. · Structure · 2006 · 214 citations · Full text

, , +7

Small-molecule factor B inhibitor for the treatment of complement-mediated diseases

Anna Schubart, Karen Anderson, Nello Mainolfi et al. · Proceedings of the National Academy of Sciences · 2019 · 206 citations · Full text

, , +23

Subcellular localization suggests novel functions for prolyl endopeptidase in protein secretion

Ingo Schulz, Ulrike Zeitschel, Thomas Rudolph et al. · Journal of Neurochemistry · 2005 · 101 citations · Full text

Modulation of inositol 1,4,5‐triphosphate concentration by prolyl endopeptidase inhibition

Ingo Schulz, Bernd Gerhartz, Antje Neubauer et al. · European Journal of Biochemistry · 2002 · 99 citations · Full text

Rows per page

1–5 of 28